Login

Dr. Peter Suzdak, CEO of Rexahn Pharmaceuticals 00:00:00

Share On Facebook Share On Twitter

Corporate Profile interviews Dr. Peter Suzdak, CEO of Rexahn Pharmaceuticals (RNN)

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
working on mission-driven startups with a sustainable social impact|Kasem Rodriguez Mohsen,Founding Partner,Equilibrium Impact Ventures
00:10:00
Behavioral Finance: Market Implications by Marise Bester | Marise Bester, Allan Gray
00:10:00
Frontiers Diamond Mining: Optimizing Production and Growth Potential
00:10:00
Pioneering High-Grade Iron Ore for the Green Steel Revolution | David Cataford, CEO , Champion Iron Ltd.
00:10:00
Market Performance Review: May Insights with Peter Smith and Dean Cook | Aviva Investors
00:10:00
Seth Ravin, president and CEO of Rimini Street Inc., discusses his role and the company's software support services.
00:10:00
John Zito, portfolio manager for credit opportunities at Brencourt Advisors LLC, discusses Tokyo Electric Power Co during a presentation or interview.
00:10:00
Jean-François Fallacher, CEO of Orange Polska, discusses his goals for 2020 and collaborations with Ericsson and Orange France.
00:10:00
NRG Energy CEO Mauricio Gutierrez discusses promoting racial equality and the company's outlook on "Squawk on the Street."
00:10:00
A Conversation with Shuhai Abe on Japan's Economic Potential and Investment Strategies | Shuhei Abe , CEO , SPARX Group.
00:10:00
Vietnam's Offshore Wind Potential: A Prime Opportunity for Development and Success | Markus Lesser, CEO , PNE AG .
00:10:00
Shreevar Kheruka on Leading Borosil: Building Multi-Generational Wealth and Transforming Family Business | Shreevar Kheruka, Managing Director, Borosil Ltd.

© 2017 - Neuhu+